Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vertex Pharmaceuticals Incorporated (VRTX)

229.06   -4.85 (-2.07%) 01-24 16:00
Open: 234.07 Pre. Close: 233.91
High: 235.18 Low: 228.415
Volume: 904,271 Market Cap: 58903M
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 235.462 - 236.934 236.934 - 237.972
Low: 224.931 - 226.761 226.761 - 228.051
Close: 226.671 - 229.335 229.335 - 231.213

Technical analysis

as of: 2020-01-24 4:36:41 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 277.36     One year: 323.96
Support: Support1: 223.31    Support2: 214.55
Resistance: Resistance1: 237.47    Resistance2: 277.36
Pivot: 229.96
Moving Average: MA(5): 233.48     MA(20): 227.40
MA(100): 201.12     MA(250): 187.69
MACD: MACD(12,26): 4.13     Signal(9): 4.21
Stochastic oscillator: %K(14,3): 78.43     %D(3): 84.82
RSI: RSI(14): 54.96
52-week: High: 237.47  Low: 163.68  Change(%): 21.8
Average Vol(K): 3-Month: 132369  10-Days: 128299

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
VRTX has closed above bottom band by 45.5%. Bollinger Bands are 15.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy?
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT )(reported strong fourth-quarter results and issued in-line guidance) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) Bristol-Myers Squibb Co (NYSE: BMY ) Cardiovascular Systems Inc (NASDAQ: CSII ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Eli Lilly And Co (NYSE: LLY ) Fortress Biotech (NASDAQ: FBIO ) Horizon Therapeutics PLC (NASDAQ: HZNP )( received FDA nod for its thyroid eye disease drug) Insulet Corporation (NASDAQ: PODD ) Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR )(announced coverage in Israel for its Optune in combination with temozolomide for the treatment of newly-diagnosed glioblastoma) Prevail Therapeutics Inc (NASDAQ: PRVL ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Selecta Biosciences Inc (NASDAQ: SELB ) SI-Bone Inc (NASDAQ: SIBN ) Soligenix, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 257.15
Shares Float (M) 256.82
% Held by Insiders 0.09
% Held by Institutions 98.70
Shares Short (K) 3950
Shares Short P. Month (K)

Stock Financials

EPS 8.240
Book Value (p.s.) 20.420
PEG Ratio 1.65
Profit Margin 59.24
Operating Margin 22.26
Return on Assets (ttm) 8.3
Return on Equity (ttm) 51.8
Qtrly Rev. Growth 21.1
Gross Profit (p.s.) 4.744
Sales Per Share
EBITDA (p.s.) 3.521
Qtrly Earnings Growth -55.30
Operating Cash Flow (M) 1440.00
Levered Free Cash Flow (M) 1070.00

Stock Valuations

P/E 27.80
P/E Growth Ratio -0.02
P/BV 11.22
P/S 16.19
P/CF 40.90

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.